BARCELONA (Reuters) - AstraZeneca's new pill Brilinta for preventing heart attacks works better than Plavix, the world's second biggest selling drug, without increasing the amount of life-threatening ...

HOUSTON--(BUSINESS WIRE)--The Lanier Law Firm is serving as outside legal counsel for the State of Texas and Attorney General Ken Paxton in a lawsuit against pharmaceutical giants Bristol-Myers Squibb ...

Texas Attorney General Ken Paxton escalated his campaign against major drugmakers this week, filing a new lawsuit accusing Sanofi SA (NASDAQ: SNY) and Bristol-Myers Squibb Co (NYSE: BMY) of concealing ...

CHICAGO -- For prolonged antithrombotic treatment after percutaneous coronary intervention (PCI), clopidogrel monotherapy was more effective and at least as safe as aspirin monotherapy in a high-risk ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. HONOLULU (AP) — Pharmaceutical companies ...

NEW YORK, Oct 23 (Reuters) - A small study presented on Monday suggests Eli Lilly and Co.'s experimental blood clot preventer prasugrel works faster and could be more effective than the commonly used ...

BOSTON (MarketWatch) -- News that Bristol-Myers Squibb and partner Sanofi-Aventis may have successfully warded off early generic competition for their blockbuster drug Plavix stoked trading of drug ...

HONOLULU — Pharmaceutical companies have agreed to pay Hawaii $700 million to settle its lawsuit over the efficacy and safety of the blood thinner Plavix, the state attorney general's office announced ...